12:00 AM
 | 
Dec 07, 2009
 |  BC Week In Review  |  Company News  |  Deals

Intercytex Group plc, Pfizer deal

Pfizer acquired undisclosed stem cell therapy assets from Intercytex's Axordia Ltd. subsidiary for $750,000. Intercytex will use the funds to support ongoing costs. In July, the biotech reduced headcount and said it had...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >